Source: Annual Congress 2008 - New insights into COPD pathophysiology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Saetta (Padova, Italy). Inflammatory pathways in COPD. What we know and potential clinical implications. Annual Congress 2008 - New insights into COPD pathophysiology

Member's Comments

No comment yet.

Related content which might interest you: Dual pathways of asthmatic inflammation and clinical implications Source: Annual Congress 2003 - New insights in airway inflammation Year: 2003 Inflammatory cells and airway remodelling in COPD: clinical implications Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 Clinical implications of the new concepts regarding COPD pathophysiology Source: Annual Congress 2008 - New insights into COPD pathophysiology Year: 2008 COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007 To progress understanding of disease triggers and modifiers in sarcoidosis, stratification is the key Source: Eur Respir J, 50 (6) 1702002; 10.1183/13993003.02002-2017 Year: 2017 Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019 Year: 2020 Dynapenia in COPD exacerbation: what is its relevance in clinical prognosis? Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy Year: 2017 The role of antioxidant enzymes in the pathogenesis of asthma and the formation of the features of its clinical course Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Are genetic defects of dienin a key link in the pathogenesis of COPD? Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 COPD as a lung disease with heterogeneous systemic inflammatory consequences: clinical impact Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011 Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Biological and therapeutic implications of the united airways disease concept Source: Annual Congress 2005 - PG18 - Inter-relationships between upper and lower airway diseases Year: 2005 Biomarkers for fibrotic lung disease - new clinical benchmarks from the lab? Source: Annual Congress 2013 –ME3 Biomarkers for fibrotic lung disease – new clinical benchmarks from the lab? Year: 2013 Functional Respiratory Imaging as a sensitive biomarker to assess therapeutic interventions in lung diseases Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles Year: 2015 Chronic diseases like asthma and COPD: do they truly exist? Source: Eur Respir J 2016; 47: 359-361 Year: 2016 Who should receive which biologic and why? Current and future approaches in severe asthma patients Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021 Individual dynamic of inflammatory markers as indicators of COPD treatment effectiveness Source: International Congress 2014 – COPD: points to ponder Year: 2014 Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014